Stories from United States

A lightning strike destroyed a three-story tall dinosaur animatronic at a theme park in Kansas. The strike left only the skeleton of the structure behind.

The trend occurs while the potential use of pythons in leather production and pharmaceuticals is being considered.

An individual was treated for a non-life-threatening gunshot wound at White Oak Medical Center. Investigators determined the person was involved in a fight at Blake. Superintendent Dr. Thomas Taylor stated the altercation was initiated by an unwelcome adult on campus.

The United States government has issued a warning to Florida residents regarding the consumption of Burmese python meat. The meat contains high levels of mercury, comparable to pollutant levels found in regional fish.

PayPal is reportedly planning to spin off Venmo into an independent business unit.

Senator Nyamu has introduced legislation aimed at regulating the use of artificial intelligence.

Boeing has developed a concept to transform the CH-47 Chinook helicopter into a drone swarm controller for airborne warfare.

A United Nations Security Council resolution supported by Bahrain to coordinate the protection of commercial shipping through arms was blocked by vetoes from China and Russia. The move comes amid ongoing global economic instability affecting transport and food prices. The resolution aimed to address maritime security and freedom of navigation. The move occurs as efforts to find a political formula for the conflict continue. Issues including freedom of navigation and security guarantees remain unresolved. The proposal is moving forward to the Executive Yuan for approval, after which the Ministry of Foreign Affairs will proceed with implementation and report to the State Council. Concerns were raised about the potential for small, unmonitored groups to acquire weapons in the Asian region, leading to instability and conflict.

The FDA has granted breakthrough therapy designation to MDMA-assisted psychotherapy for the treatment of certain conditions. Researchers are currently studying the use of substances including LSD, Ketamine, MDMA, and Ibogaine. The agency noted a need to better understand potential complications of using psychedelics in medical settings. This follows a 2024 FDA rule against MDMA for PTSD. The exact mechanism of how MDMA works in the brain remains unclear, according to the source. The designation follows research involving a sample size of 30 per disorder using 'leave-one-out' analyses.

The FDA has authorized a clinical study for a medication derived from Ibogaine, a psychedelic extracted from an African shrub. The pharmaceutical company conducting the study intends to use the drug to treat alcoholism. This marks the first clinical study allowed in the United States for an Ibogaine-related substance. The study is part of a broader pilot program launched last year. Researchers noted that progress in this field has been slow due to the difficulty of obtaining approval for research involving these substances. The study is part of broader research into various substances in different stages of development.